Supreme Living Logo About Us Our Products Career Opportunities What's On News Room Contact Us
 

References

Anderson JW, Johnstone BM, Cook-Newell ME. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med. 1995; 333:276-282.

Aoyama T, Fukui K, Takamatsu K, et al. Soy protein isolate and its hydrolysate reduce body fat of dietary obese rats and genetically obese mice (yellow KK). Nutrition. 2000; 16:349-354.

Carroll KK. Review of clinical studies on cholesterol-lowering response to soy protein. J Am Diet Assoc. 1991; 91:820-827.

Carroll KK, Kurowska EM. Soy consumption and cholesterol reduction: review of animal and human studies. J Nutr. 1995; 125(3Suppl):594S-597S.

Crouse JR III, Morgan T, Terry JG, et al. A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins. Arch Intern Med. 1999; 159:2070-2076.

Erdman JW Jr. Control of serum lipids with soy protein (Editorial). N Eng J Med. 1995; 333:313-315.

Gaddi A, Decovich GC, Noseda G, et al. Hypercholesterolemia treated by soybean protein diet. Arch Dis Childhood. 1987; 62:274-278.

Galvez AF, deLumen BO. A soybean cDNA encoding a chromatin-binding peptide inhibits mitosis of mammalian cells. Nat Biotechol. 1999; 17:495-500.

Greaves KA, Wilson MD, Rudel LL, et al. Consumption of soy protein reduces cholesterol absorption compared to casein protein alone or supplemented with an isoflavone extract or conjugated equine estrogen in ovariectomized cynomolgus monkeys. J Nutr. 2000; 130:820.

Teixeira SR, Potter SM, Weigel R, et al. Effects of feeding 4 levels of soy protein for 3 and 6 wk on blood lipids and apolipoproteins in moderately hypercholesterolemic men. Am J Clin Nutr. 2000; 71:1077-1084.

Wang W, Higuch CM. Dietary soy protein is associated with reduced intestinal mucosal polyamine concentration in male Wistar rats. J Nutr. 2000; 130:1815-1820.

Ayehunie S, Belay A, Baba TW, Ruprecht RM. Inhibition of HIV-1 replication by an aqueous extract of Spirulina platensis (Arthrospira platensis). J Acquir Immune Defic Synd Hum Retrovirol. 1998; 18:7-12.

Chamorro G, Salazar M, Favil L, Bourges H. [Pharmacology and toxicology of Spirulina alga.] [Article in Spanish.] Rev Invest Clin. 1996; 48:389-399.

Devi MA, Venkataraman LV. Hypocholesterolemic effect of blue-green algae Spirulina platensis in albino rats. Ann Nutr Reports Int. 1983; 28:519-530.

Hayashi T, Hayashi K. Calcium spirulan, an inhibitor of enveloped virus replication, from a blue-green alga Spirulina platensis. 1996; 59:83-87.

Hayashi K, Hayashi T, Morita N, Kajima I. An extract from Spirulina platensis is a selective inhibitor of herpes simplex virus type 1 penetration into HeLa cells. Phytotherapy Res. 1993; 7:76-80.

Lissi EA, Pizarro M, Aspee A, Romay C. Kinetics of phycocyanine bilin groups destruction by peroxyl radicals. Free Rad Biol Med. 2000; 28:1051-1055.

Miranda MS, Cintra RG, Barros SB, Mancini Filho J. Antioxidant activity of the microalga Spirulina maxima. Braz J Med Biol Res. 1998; 31:1075-1079.

Quereshi MA, Ali RA. Spirulina platensis exposure enhances macrophage phagocytic function in cats. Immunopharmacol Immunotoxicol. 1996; 18:457-463.

Quereshi MA, Garlich JD, Kidd MT. Dietary Spirulina platensis enhances humoral and cell-mediated functions in chickens. Immunopharmacol Immunotoxicol. 1996; 18:465-476.

Romay C, Armesto J, Ramirez D, et al. Antioxidant and anti-inflammatory properties of C-phycocyanin from blue-green algae. Inflamm Res. 1998; 47:36-41.

Watanabe F, Katsura H, Takenaka S, et al. Pseudovitamin B12 is the predominant cobamide of an algal health food, spirulina tablets. J Agric Food Chem. 1999; 47:4736-4741.

Breinholt V, Arbogast D, Loveland P, et al. Chlorophyllin chemoprevention: an evaluation of reduced bioavailability vs. target organ protective mechanisms. Toxicol Appl Pharmacol. 1999; 158:141-151.

Chernomorsky S, Segelman A, Poretz RD. Effect of dietary chlorophyll derivatives on mutagenesis and tumor cell growth. Teratogen Carcinogen Mutagen. 1999; 19:313-322.

Dashwood RH, Breinholt V, Bailey GS. Chemopreventive properties of chlorophyllin: inhibition of aflatoxin B1 (AFB1)-DNA binding in vivo and antimutagenic activity against AFB1 and two heterocyclic amines in the Salmonella mutagenicity assay. Carcinogenesis. 1991; 12:939-942.

Nahata MC, Slencsak CA, Kamp J. Effect of chlorophyllin on urinary odor in incontinent geriartric patients. Drug Intell Clin Pharm. 1983; 17:732-734.

Te C, Gentile JM, Baguley BC, et al. In vivo effects of chlorophyllin on the antitumot agent cyclophosphamide. Int J Cancer. 1997; 70:84-89.

Young RW, Beregi JS Jr. Use of chlorophyllin in the care of geriatric patients. J Am Geriatr Soc. 1980; 28:46-47.

B.V. McCleary and Prosky, L. (eds) 2001. Advanced Dietary Fibre Technology. Blackwell Science, Oxford.

Gibson, G.R. and Roberfroid, M.B. 1995. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. Journal of Nutrition. 125:1401-1412.

footer
  引用 | 使用条件 | 免责声明